Navigation Links
Corporate Partners Commit to the Crohn's & Colitis Foundation Mission to Cure Digestive Diseases

Centocor Ortho Biotech, Lifeway Kiefr, and Shire Sign On As Take Steps Walk Corporate Supporters

New York, NY (Vocus) May 24, 2010 -- The Crohn’s & Colitis Foundation announced today that Centocor Ortho Biotech, Lifeway Kiefr, and Shire will participate as official national sponsors of the Foundation’s Take Steps Walk program in 2010. The corporate sponsors are supporting 100 Take Steps Walks this spring and summer in communities around the country. Walkers will raise much-needed dollars for research into Crohn's disease and ulcerative colitis, chronic, painful, and often debilitating digestive diseases. Collectively known as inflammatory bowel diseases (IBD), Crohn's and colitis afflict over 1.4 million American children and adults.

As acknowledgment of their partnership the logos of these companies will appear on Take Steps signs, printed materials, T-shirts, and web sites.

“The Crohn’s & Colitis Foundation is so appreciative for the generous support we are receiving from Centocor Ortho Biotech, Lifeway Kiefr, and Shire in 2010,” said Richard J. Geswell, President of the Crohn’s & Colitis Foundation of America. “Their involvement in Take Steps critically helps support the Walks which are the foundation for research investments to find better therapies and ultimately a cure for these debilitating digestive diseases.”

The number of people with newly diagnosed IBD has significantly increased in recent years and there is no known cure. The Crohn's & Colitis Foundation has defined the field of IBD research for nearly a half-century, enabling the best scientists to discover better therapies and ultimately, a cure. In the past two years alone, over 75,000 Americans participated in Take Steps, raising over $13 million to help the Foundation fund research, education, and support initiatives. Visit today to find a Take Steps walk in your community.

About Crohn's Disease & Ulcerative Colitis
Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.

About the Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 79 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance ( and the American Institute of Philanthropy ( For more information, contact the Foundation at 800-932-2423 or visit Join CCFA on Facebook at and follow CCFA on Twitter at

Centocor Ortho Biotech Inc. redefines the standard of care in immunology, nephrology and oncology. Built upon a pioneering history, Centocor Ortho Biotech Inc. harnesses innovations in large-molecule and small-molecule research to create important new therapeutic options. Beyond its innovative medicines, Centocor Ortho Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates and healthcare professionals have access to the latest treatment information, support services and quality care. For more information about Centocor Ortho Biotech, visit

As the nation’s largest family-run kefir company, Lifeway cares about your health. That’s why we’re thrilled to announce our 2010 national sponsorship for the Crohn’s & Colitis Foundation. Our probiotic-rich kefir is naturally brimming with 10 strains of live and active cultures which work to calm intestinal irritation and improve symptoms and quality of life in patients with Crohn’s Disease and Ulcerative Colitis. We encourage you to try our product and hope you will include it as a naturally powerful tool in your arsenal of weapons for managing your condition. Drink kefir – to your health!

Shire is a leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician, and focuses on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases. For further information on Shire, visit

Media Contact:
Ariella Levine


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Corporate health program reduces employee CVD medical, hospital costs
2. Lice Control™ Incorporates the Revolutionary LouseBuster™ Device in its Head Lice Removal Arsenal in Northern California
3. Astra HR Moves its Corporate Headquarters to King Farm, Rockville, MD
4. Leading Corporate Consulting Firm Says U.S. Companies are Re-focusing on Corporate Strategic Planning
5. Innoport Hosted Unified Communications Service Incorporates Call Queuing and Automated Call Distribution (ACD)
6. PricewaterhouseCoopers Wins Film Festival For Top Corporate Responsibility Video
7. McGraw-Hill Signs Corporate Visions Experts to Book Deal
8. names Corporate Visions as Top 20 Sales Training Firm
9. Society of Corporate Compliance and Ethics Testifies at U.S. Sentencing Commission March 17, 2010 Hearing on Proposed Amendments
10. Konamoxt, Inc. Redefines Corporate Wellness with The Healthy Corp, a Customizable Corporate Wellness Platform
11. Choice of Derek H. Lee as Chief Financial and Corporate Development Officer Strengthens Talaris Advisors' Portfolio Design Business Model
Post Your Comments:
Related Image:
Corporate Partners Commit to the Crohn's & Colitis Foundation Mission to Cure Digestive Diseases
(Date:10/13/2017)... LEXINGTON, Ky. (PRWEB) , ... October 13, 2017 , ... ... MD, MPH to become its next President and Chief Executive Officer, succeeding Dr. James ... and CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: